Preview Mode Links will not work in preview mode

ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

Feb 28, 2023

Clinicians need more tools to reduce the number of unnecessary tests. Clinical likelihood models represent such tools, and this study demonstrated favorable prognosis for patients who were deferred for testing using the risk factor-weighted clinical likelihood model and the coronary artery calcium score-weighted...


Feb 21, 2023

The PRECISE trial examined how to evaluate patients with chest pain most effectively, minimizing unnecessary testing.

 In this interview, Pamela S. Douglas MD MACC, FASE, FAHA and Richard A. Chazal MD, MACC discuss PRECISE – Comparison of a Precision Care Strategy with Usual Testing to Guide Management of Stable...


Feb 14, 2023

Iron deficiency is very common in patients with heart failure, affecting between one third to a half of all patients. IRONMAN will help determine if treatment with intravenous iron can help patients feel better, and reduce the risk of being hospitalized for heart failure or dying.

 In this interview, Professor...


Feb 7, 2023

In this contemporary population of statin-treated patients with type 2 diabetes and hypertriglyceridemia, 1 in 10 developed a cardiovascular event by 3 years, and despite 20-30% reductions of triglycerides and what we call remnant cholesterol with a fibrate-like therapy, there was no clinical benefit.

In this interview,...